Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perispinal etanercept for chronic stroke
ACTRN12615001377527Phase 2Recruiting
- Sponsor
- Griffith University
- Start
- Nov 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of etanercept in stroke (2 arms), sponsored by Griffith University. Primary endpoints: Sustained change in chronic post-stroke pain, Overall change in chronic post-stroke pain and 1 more. Started Nov 2017; status: recruiting.
02
Drugs
etanercept
03
Conditions
stroke
Beyond the preview
Go deeper on ACTRN12615001377527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001377527.